Bsi Inc

PURPOSE: THE WIRELESS HEART OF AMERICA (WHOA) PROJECT AIMS TO RE-ESTABLISH US LEADERSHIP IN THE RU MARKET BY INTRODUCING TECHNOLOGY SOLUTIONS, READY TO COMPETE WITH THE GLOBAL LEADER IN THE MARKET FOR VERY-LARGE-ARRAY (VLA) MASSIVE MULTIPLE INPUT-MULTIPLE OUTPUT (MIMO) OPEN RADIO UNITS (O-RUS). ACTIVITIES TO BE PERFORMED: DEVELOPING AND COMMERCIALIZING TWO VLA O-RU MODELS BASED ON ABSIDE NETWORKS INNOVATIVE RF-RETINA TECHNOLOGY, WITH A CLEAR TOTAL COST OF OWNERSHIP RETURN ON INVESTMENT: 50% CAPACITY INCREASE IN MOUNTAINOUS REGIONS VIA ELEVATION SECTORIZATION AND 30% COVERAGE AND CAPACITY INCREASE IN OTHER DEPLOYMENT SCENARIOS, THUS REDUCING REQUIRED TOWER DENSITIES. DEVELOPING A US-BASED MANUFACTURING-AT-SCALE PLAN, WHILE MAXIMIZING THE USE OF US COMPONENTS VENDORS FOR AN INCREASED SUPPLY CHAIN RESILIENCE. EXPECTED OUTCOMES: FORMING A CONSORTIUM LED BY THE OPERATORS, WHICH WILL ACT AS THE LIVING REPOSITORY FOR ALL MANUFACTURING AND INTEGRATION EFFORTS OF TEAM WHOA. THIS WILL ENSURE THE BEST USE OF FUNDS DISBURSED TOWARDS COMMERCIALIZATION, ATTRACTING BOTH NEW OPERATORS AND VENDORS BY LOWERING OVERHEAD COSTS OF O-RAN DEPLOYMENTS. THE IMPACT ON THE DEPLOYMENT PLANS AND BUSINESSES OF APPROXIMATELY 90 REGIONAL MOBILE NETWORK OPERATORS (MNOS) WILL BE NEAR-IMMEDIATE: A) DRASTICALLY REDUCED NETWORK DEPLOYMENT COSTS B) ENABLE FIXED WIRELESS ACCESS MARKET EXPANSION FOR REGIONAL MNOS AS THEY SEEK TO ADDRESS UNSERVED AND UNDERSERVED CUSTOMERS C) ENHANCED SERVICE OFFERINGS FOR THE COMMUNITIES THEY SERVE. INTENDED BENEFICIARIES: REGIONAL MNOS THAT HAVE BEEN PREVIOUSLY DOMINATED BY FOREIGN VENDORS. THE LACK OF CHOICE HAS FORCED THESE REGIONAL MNOS TO UTILIZE LESS CAPABLE TECHNOLOGY AND PROCURE COSTLIER ALTERNATIVES TO PROVIDE SERVICE. SUBRECIPIENT ACTIVITIES: NORTHEASTERN AND VIRGINIA TECH WILL SUPPORT O-RAN AND CYBER SECURITY COMPLIANCE TESTING, LEVERAGING NTIAS NOFO1 PROJECT EXPERIENCE; CRITICAL WORLD-RENOWNED SPECIALIZED SUPPORTING ENTITIES FOR PROJECT MANAGEMENT, SUPPLY CHAIN, MANUFACTURING, AND MARKET ANALYSIS.

DEVELOPMENT OF AN INNOVATIVE MATERIAL FOR TRANSCATHETER PERIPHERAL EMBOLIZATION - PROJECT SUMMARY HEMORRHAGE AND UNCONTROLLED BLEEDING ARE A LEADING CAUSE OF DEATH, AND WHEN NOT FATAL CAN RESULT IN ADVERSE HEALTH OUTCOMES WITH LONG TERM NEGATIVE CONSEQUENCES INCLUDING ORGAN DAMAGE OR FAILURE, AND COMA. UNCONTROLLED BLEEDING CAN ARISE FROM A VARIETY OF DISEASES, TRAUMATIC INJURIES, AND HEALTH CONDITIONS, SUCH AS ATRIAL FIBRILLATION, WHICH AFFLICTS OVER 2.6M PEOPLE IN THE UNITED STATES. MOST ATRIAL FIBRILLATION PATIENTS ARE REQUIRED TO TAKE ANTICOAGULANTS (ACAS). THE STANDARD OF CARE (SOC) FOR INTERNAL HEMORRHAGE IS TRANSCATHETER EMBOLIZATION TO OCCLUDE THE BLEEDING ARTERY OR VEIN, HOWEVER, THERE ARE MAJOR DRAWBACKS OF CURRENTLY AVAILABLE METHODS, INCLUDING HIGH COST, LACK OF COMPLETE OCCLUSION, RELIANCE ON PATIENT COAGULATION, DIFFICULTLY OF PROPER ADMINISTRATION, IMAGING ARTIFACTS, AND THE CHANCE OF MIGRATION OR FRAGMENTATION OF THE MATERIAL. THERE IS A SIGNIFICANT UNMENT NEED FOR EMBOLIZATION MATERIALS THAT ARE COMPATIBLE WITH ACAS, ARE EASY TO USE, AND ARE EFFECTIVE AND SAFE FOR USE. TO ADDRESS THIS NEED, IN THIS FAST-TRACK PROPOSAL OBSIDIO, INC IS DEVELOPING AN INNOVATIVE EMBOLIC MATERIAL CALLED SHEAR-THINNING BIOMATIERAL (STB) THAT HAS THE QUALITIES REQUIRED FOR A VERSATILE AND EFFECTIVE EMBOLIC MATERIAL. STB IS READY TO USE AND DOES NOT REQUIRE MIXING OR PREPARATION, IS EASY TO ADMINISTER VIA STANDARD MICROCATHETERS, CAN BE DELIVERED OVER A SHORT OR EXTENDED TIME PERIOD WITHOUT FEAR OF CLOGGING THE CATHETER, DOES NOT PRODUCE AN IMAGE ARTIFACT AFTER ADMINISTRATION, AND IS COMPRISED OF MATERIALS THAT ARE SAFE AND BIOCOMPATIBLE. MOREOVER, STB IS A MORE COST-EFFECTIVE OPTION FOR BOTH PATIENTS AND HOSPITALS AND DOES NOT REQUIRE THE SAME LEVEL OF EXPERTISE TO ADMINISTER AS OTHER METHODS.THE OBJECTIVE OF THIS FAST-TRACK PROPOSAL IS TO DEVELOP A CLINICAL-GRADE FORMULATION OF STB FOR PERIPHERAL HEMORRHAGE CONTROL AND INITATE A DESIGN FREEZE, DEMONSTRATE SAFETY OF BOTH THE BIOMATERIAL AND THE DEVICE THROUGH EX VIVO AND IN VIVO STUDIES, AND COMPLETE THE TESTING REQUIRED BY THE FDA INCLUDING BIOCOMPATIBILITY STUDIES AND GLP ANIMAL STUDIES. IN PHASE I OF THE FAST-TRACK WE PROPOSE TO FINALIZE STB FORMULATION, VALIDATE THE SAFETY AND EFFICACY OF CLINICAL- GRADE STB, AND EVALUATE ITS PERFORMANCE IN A NON-GLP RODENT MODEL. IN PHASE II OF THE FAST-TRACK WE PROPOSE TO VALIDATE STB PERFORMANCE IN A NON-GLP BLEEDING PORCINE MODEL OF HEMORRHAGE, FOLLOWED BY ISO-10993 BIOCOMPATBILITY STUDIES TO CONFIRM SAFETY OF THE BIOMATEIRALS, INCLUDING AN IN VITRO IN VIVO CORRELATION STUDIES TO DETERMINE THE DEGRADATION OF STB. FINALLY, WE WILL CONDUCT GLP STUDIES IN A PORCINE MODEL TO CHARACTERIZE THE PERFORMANCE AND SAFETY OF STB. SUCCESSFUL COMPLETION OF THIS WORK WITH ENABLE OBSIDIO TO ADVANCE TO 510K CLEARANCE FOR STB USED IN PERIPHERAL HEMORRHAGE. OVERALL, DEVELOPMENT OF THIS NOVEL BIOMATERIAL WILL PROVIDE PHYSCIANS A NOVEL EMBOLIZATION OPTION WITH SUPERIOR PERFORMANCE AND VERSATILITY THAT WILL ULTIMATELY HELP TO SAVE HUNDREDS OF THOUSANDS OF LIVES ANNUALLY.

SBIR PHASE II: HIGH RESOLUTION TERAHERTZ VIDEO CAMERA FOR MEDICAL IMAGING -THIS SMALL BUSINESS INNOVATION RESEARCH PHASE II PROJECT WILL DEVELOP AND LAUNCH A NEW, COMMERCIALLY VIABLE TERAHERTZ (THZ) IMAGING TECHNOLOGY INITIALLY TARGETED AT MEDICAL IMAGING APPLICATIONS. THE PROTOTYPE INSTRUMENT USES THZ REFLECTIVE IMAGING PHENOMENOLOGY, A TECHNIQUE THAT HAS BEEN SHOWN TO EFFICIENTLY DISCRIMINATE BETWEEN HEALTHY AND DISEASED TISSUES. WITH A RESOLUTION OF MORE THAN 300X300 PIXELS, OPERATION AT BETWEEN 10-30 FRAMES PER SECOND, AND A COMPACT FORM FACTOR, THE SYSTEM IS APPROPRIATE FOR MEDICAL ENVIRONMENTS SUCH AS CANCER SURGERIES, INCLUDING GLIOBLASTOMA RESECTION. THE THZ CAMERA WILL BE A NEW ADDITION TO THE MEDICAL IMAGING MARKET THAT HAS MATURED WITH X-RAY, MRI, VISIBLE AND INFRARED TECHNOLOGIES TO REACH $45 BILLION. THIS NEW INSTRUMENT IS ENABLED BY A LARGE FORMAT SENSOR ARRAY THAT USES A LOW-COST MANUFACTURING PROCESS ALREADY IMPLEMENTED IN A HIGH-VOLUME FOUNDRY. IN ADDITION TO THE MEDICAL APPLICATION, SIMILAR IMAGING SYSTEMS CAN BE USED IN SECURITY SCREENING APPLICATIONS ($2 BILLION MARKET/YEAR) SUCH AS PASSENGER SCREENING AT AIRPORTS. MORE BROADLY, THE UNDERLYING SENSOR TECHNOLOGY CAN BE ADAPTED FOR USE ACROSS THE EXTREMELY WIDE THZ SPECTRUM, WHICH HAS IMPLICATIONS FOR MANY INDUSTRIES. THE INTELLECTUAL MERIT OF THIS PROJECT IS PRIMARILY ITS INTEGRATION OF BOTH HIGH RESOLUTION AND HIGH-SPEED ASPECTS OF THZ IMAGING, AS THESE CAPABILITIES HAVE NOT YET BEEN DEMONSTRATED IN A COMMERCIALLY VIABLE FORM. PREVIOUS DEMONSTRATIONS HAVE EITHER INVOLVED SLOW SCANNING SYSTEMS THAT PRECLUDE REAL TIME APPLICATIONS OR CAMERAS THAT TARGET MUCH HIGHER BANDS OF THE THZ SPECTRUM. THE LATTER RESTRICTION STEMS FROM AN INABILITY TO MANUFACTURE ARRAYS OF LARGE PIXELS TO IMAGE AT THE LONGER THZ WAVELENGTHS. GOING BEYOND ONE OF A KIND LABORATORY PROOF OF CONCEPT EXPERIMENTS, THE THZ CAMERA SEEKS TO PROVIDE RESOLUTION AND FRAME UPDATE RATES THAT ARE RELEVANT TO ACTUAL APPLICATIONS. THE COMMERCIAL MANUFACTURING VIABILITY OF THE SENSING ELEMENT MAY ENSURE THAT APPLICATIONS BEYOND THE INITIAL MEDICAL MARKET WILL BE PRACTICAL. THE CAMERA WILL FEATURE NOT ONLY THE HIGH-RESOLUTION THZ IMAGING NEAR THE 250-350 GHZ SPECTRUM BUT ALSO INCORPORATE HIGH-RESOLUTION VISIBLE AND NEAR-INFRARED CAMERAS THAT CAN COMPLEMENT THE THZ VIDEO, WITH TRIALS BEING PLANNED FOR HOSPITAL USAGE. IN ADDITION TO CLINICAL USAGE SCENARIOS, THE IMAGING SYSTEM CAN BE ADAPTED FOR USE IN AIRPORT SECURITY AND OTHER SCREENING APPLICATIONS, AS PORTABILITY AND EASE OF USE WILL GUIDE THE DEMONSTRATION SYSTEM DESIGN. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.

HIGH THROUGHPUT MASS SPECTROMETRY TO EXPLOIT GENETIC DIFFERENCES IN SAME-LENGTH STR ALLELES

IN THIS ERA OF FAST DEVELOPMENTS AND FREQUENT LAUNCHES OF SMALL SATELLITES IN THE PUBLIC AND PRIVATE SECTORS RAPID SCIENTIFIC STUDIES AND PUBLIC-PRIVATE COLLABORATIONS ARE NEEDED TO ENSURE BEST USE OF THE NEW SATELLITE DATA. ONE SUCH MISSION THE NA

ROSS PH SVC COORDINATOR

RESIDENT OPPORTUNITY AND SUPPORTIVE SERVICES - SERVICE COORDINATORS

RESIDENT OPPORTUNITY AND SUPPORTIVE SERVICES - SERVICE COORDINATORS

RESIDENT OPPORTUNITY AND SUPPORTIVE SERVICES - SERVICE COORDINATORS

SBIR PHASE I: HIGH RESOLUTION TERAHERTZ VIDEO CAMERA FOR PEOPLE SCREENING AND MEDICAL IMAGING

SBIR PHASE I: INTEGRATED ADDITIVE MANUFACTURING

SBIR PHASE I: DEVELOPMENT OF AN INJECTABLE SHEAR THINNING BIOMATERIAL FOR THE TREATMENT OF ANEURYSMS

3D PRINTING OF HIGH PRECISION RADIATION FILTERS FOR NEXT GENERATION COSMIC BACKGROUND (CMB) STUDIES

IMPROVING THE PROPERTIES OF LAMINATED VENEER LUMBER MADE FROM SOUTHERN YELLOW PINE THROUGH MICROWAVE TREATMENT

THE CHAMPIONING RURAL FARMS WHOLE PROJECT'S PURPOSE IS TO GROW DISTRIBUTION CHANNELS FOR RURAL FAMILY FARMS. CURBSIDE PROVISIONS HAS MUCH EXPERIENCE SELLING THE BENEFITS OF SUPPORTING RURAL FARMS AND HAS EMPLOYEES WITH EXPERIENCE SELLING IN THE WHOLESALE MARKET. IN ORDER TO ACHIEVE THE PROJECT'S OUTCOMES, THE PLANT IS REQUESTING FUND TO IMPROVE PROCESSING EFFICIENCY AND CAPACITY. THE ADDITION CURBSIDE PROVISIONS AS USDA INSPECTED FACILITY, WILL BUILD A STRONGER FOOD SUPPLY CHAIN AND BENEFIT SMALL RURAL FAMILY FARMS BY PROVIDING MORE OPPORTUNITY TO SELL THE MEAT TO A PROCESSOR WITH SHARED VALVES.

REAP RENEWABLE ENERGY SYSTEM (RES) GRANT UNRESTRICTED AMOUNT

RETROFIT 3 COACHES AND TRAINING

HEALTH CARE AND OTHER FACILITIES

2007 OVER-THE-ROAD BUS PROGRAM

WHEELCHAIR RETROFIT FY 2011 $

THIS GRANT SUPPORTS THE COSTS INCURRED TO IMPLEMENT MEASURES TO RESPOND TO THE NOVEL CORONAVIRUS 2019 (COVID-19), WHICH MAY INCLUDE WORKPLACE SAFETY, MARKET PIVOTS, RETROFITTING FACILITIES, TRANSPORTATION, WORKER HOUSING, AND MEDICAL EXPENSES. IT PROVIDES NEEDED RELIEF TO THE FOOD PROCESSORS, DISTRIBUTORS, FARMERS MARKETS, AND PRODUCERS FOR THEIR COSTS INCURRED BETWEEN JANUARY 27, 2020, THE DATE UPON WHICH THE PUBLIC HEALTH EMERGENCY WAS DECLARED BY THE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICE (HHS) UNDER SECTION 319 OF THE PUBLIC HEALTH SERVICE ACT, AND DECEMBER 31, 2021. BENEFICIARIES INCLUDE THE EMPLOYEES OF THE FOOD PROCESSORS, DISTRIBUTORS, FARMERS MARKETS, AND PRODUCERS.

THIS GRANT IS TO BUILD ON AN EFFECTIVE PROGRAM TO DEVELOP THE LEADERSHIP AND PRACTICAL TRADE SKILLS AND CAPACITIES OF 50-60 STUDENTS FROM RURAL AREAS